A Phase 2 Study Adding Ascorbate to Chemotherapy and Radiation Therapy for NSCLC
A Phase 2 Study Adding Ascorbate to Chemotherapy and Radiation Therapy for NSCLC
Active, not recruiting · NCT02905591 · Registry updated 2026-07-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 2 Study Adding Ascorbate to Chemotherapy and Radiation Therapy for NSCLC | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Phase 2 | 2026-07-31 | NCT02905591 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Holden Comprehensive Cancer Center | 8 |
| Joseph J. Cullen, MD, FACS | 1 |
| National Cancer Institute (NCI) | 3015 |
| National Institutes of Health (NIH) | 667 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Holden Comprehensive Cancer Cener | Iowa City | United States | 1 |